Your browser doesn't support javascript.
loading
Reduced calf muscle pump function is a risk factor for venous thromboembolism: a population-based cohort study.
Houghton, Damon E; Ashrani, Aneel; Liedl, David; Mehta, Ramila A; Hodge, David O; Rooke, Thom; Wennberg, Paul; Wysokinski, Waldemar; McBane, Robert.
Afiliação
  • Houghton DE; Division of Vascular Medicine, Department of Cardiovascular Diseases.
  • Ashrani A; Division of Hematology/Oncology, Department of Internal Medicine.
  • Liedl D; Gonda Vascular Center, and.
  • Mehta RA; Division of Hematology/Oncology, Department of Internal Medicine.
  • Hodge DO; Gonda Vascular Center, and.
  • Rooke T; Division of Biomedical Statistics and Informatics, Department of Health Science Research, Mayo Clinic, Rochester, MN; and.
  • Wennberg P; Department of Health Sciences Research, Mayo Clinic, Jacksonville, FL.
  • Wysokinski W; Division of Vascular Medicine, Department of Cardiovascular Diseases.
  • McBane R; Gonda Vascular Center, and.
Blood ; 137(23): 3284-3290, 2021 06 10.
Article em En | MEDLINE | ID: mdl-33657212
The calf muscle pump is a major determinate of venous return in the legs but has not been studied as a risk factor for venous thromboembolism (VTE). A population-based cohort study of Olmsted County, Minnesota residents was performed using calf pump function (CPF) measurements from venous plethysmography studies from 1998 to 2015. Patients with a history of VTE were excluded. Nursing validated VTE outcomes from the Rochester Epidemiology Project were identified after the index study date, and patients with reduced CPF (rCPF) were compared with patients with normal CPF. A total of 1532 patients with recorded CPF (28% air and 72% strain gauge plethysmography) were included; 591 (38.5%) had normal CPF, 353 (23.0%) had unilateral rCPF, and 588 (38.3%) had bilateral rCPF. Any VTE occurred in 87 patients (5.7%) after a median follow-up of 11.7 years (range, 0-22.0 years). Comparing patients with bilateral reduced to bilateral normal CPF, the unadjusted hazard ratio (HR) for incident VTE was 2.0 (95% confidence interval [CI], 1.2-3.4) and after adjusting for age, BMI, and Charlson Comorbidity Index, the HR was 1.68 (95% CI, 0.98-2.89). The adjusted HR for ipsilateral deep vein thrombosis was evaluated in 3064 legs comparing legs with reduced to normal CPF and was 1.71 (95% CI, 1.03-2.84). Mortality was significantly higher in both the bilateral (P < .001) and unilateral (P < .001) rCPF groups compared with normal CPF. Our results demonstrate that CPF is a risk factor for VTE in an otherwise low-risk ambulatory population and might be a useful component in risk stratification models.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Músculo Esquelético / Trombose Venosa / Tromboembolia Venosa / Modelos Cardiovasculares Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Músculo Esquelético / Trombose Venosa / Tromboembolia Venosa / Modelos Cardiovasculares Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2021 Tipo de documento: Article